To provide information, resources, support, and HOPE to those affected by advanced cancer or cancer that has spread to the liver from the original cancer
2 days ago
1 week ago
www.pharmacytimes.com
The antibody-drug conjugate shows efficacy in reducing disease progression risk and increasing progression-free survival in patients with HR+, HER2-low, or HER2-ultralow metastatic breast cancer.2 weeks ago
3 weeks ago
4 weeks ago